Ex-Pfizer drug reduces osteoarthritis pain in British biotech's phase 2 study

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Aug 06, 2024 at 11:22: AM
via Levicept arose from the metaphorical ashes of Pfizer’s former R&D campus in the U.K. Now, the biotech has scored a phase 2 win for an osteoarthritis drug that can also be traced back to the Big Pharma.

article source
 

<



Similar threads

cafead
Pfizer-licensed Cardiovascular Drug Reduces Triglycerides in Phase II
Replies
0
Views
126
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Study: Pfizer&#039;s Experimental Diabetes Drug Robustly Reduces Weight and Glucose
Replies
0
Views
172
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Pfizer rare heart disease drug reduces risk of death by 30 percent in study
Replies
1
Views
645
Pharma/Biotech Companies - In the News
anonymous
cafead
Pfizer’s Bourla confident in company’s obesity drug position, despite delays
Replies
0
Views
26
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Could Pfizer Become a Top Weight Loss Drug Stock? Don&#039;t Count on It.
Replies
0
Views
23
Pharma/Biotech Companies - In the News
cafead
cafead
Top Bottom
Back
Quote